Drug Trial Radar · NCT07150845
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Aug 26, 2025
Primary completion
Jul 23, 2026
Study completion Aug 3, 2026
Sponsor
- Lead sponsor
- Evommune, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
EVO756Drug
Dose 1
EVO756Drug
Dose 2
EVO756Drug
Dose 3
Placebo controlDrug
Placebo control
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change in Eczema Area and Severity Index (EASI) from BaselineTime frame: Week 12
Locations
29 sites in 2 countries. Site status is shown where the registry gives one.
Saguaro Dermatology
Phoenix, Arizona
Center for Dermatology Clinical Research
Fremont, California
Metropolis Dermatology - Downtown Los Angeles
Los Angeles, California
Skin and Beauty Center
Pasadena, California
Skin Care Research, LLC
Boca Raton, Florida
Driven Research, LLC
Coral Gables, Florida
Skin Care Research - Hollywood Dermatology
Hollywood, Florida
TrueBlue Clinical Research
Tampa, Florida
DS Research
Clarksville, Indiana
Equity Medical
Bowling Green, Kentucky
Aesthetic and Dermatology Center
Rockville, Maryland
Great Lakes Research Group, Inc.
Bay City, Michigan
Revival Research Institute, LLC
Troy, Michigan
Michigan Dermatology Institute
Waterford, Michigan
MediSearch Clinical Trials
Saint Joseph, Missouri
Empire Dermatology
East Syracuse, New York
Equity Medical
New York, New York
Skin Search of Rochester, Inc.
Rochester, New York
Wilmington Dermatology Center
Wilmington, North Carolina
DOCS Dermatology Clinical Research
Canal Winchester, Ohio
International Clinical Research - Murfreesboro
Murfreesboro, Tennessee
Stryde Research
Lewisville, Texas
Progressive Clinical Research
San Antonio, Texas
Jordan Valley Dermatology Center
South Jordan, Utah
Pacific Clinical Research Network (PCRN) - Christchurch
Christchurch Central City, Christchurch, New Zealand
Optimal Clinical Trials
Auckland, NZL, New Zealand
Optimal Clinical Trials
Auckland, NZL, New Zealand
Clinical Trials NZ Limited
Hamilton, NZL, New Zealand
Momentum Clinical Research Lower Hutt
Lower Hutt, NZL, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.